PSG Recommendations for Risk-based Comparative Immunogenicity and Impurity Profile Assessment
Author/sPang, Eric
Date:09/14/2023
Meeting Name:SBIA 2023 – Advancing Generic Drug Development: Translating Science to Approval
State:
City:Virtual